Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2

Conditions

Carcinoma, Non-Small-Cell Lung 911Lung Neoplasms 611Small Cell Lung Carcinoma 169Colorectal Neoplasms 136Melanoma 107Breast Neoplasms 107Ovarian Neoplasms 94Neoplasms 94Neoplasm Metastasis 90Pancreatic Neoplasms 76Squamous Cell Carcinoma of Head and Neck 70Stomach Neoplasms 60Carcinoma, Renal Cell 57Head and Neck Neoplasms 55Triple Negative Breast Neoplasms 51Endometrial Neoplasms 51Esophageal Neoplasms 50Prostatic Neoplasms 46Uterine Cervical Neoplasms 44Colonic Neoplasms 41Urinary Bladder Neoplasms 40Mesothelioma 39Carcinoma, Hepatocellular 38Mesothelioma, Malignant 36Brain Neoplasms 32Carcinoma, Transitional Cell 29Sarcoma 28Adenocarcinoma of Lung 28Disease 26Lung Diseases 24

Interventions

pembrolizumab 1cediranib 1Platinum 1Pharmacogenomic Testing 1Pemetrexed 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Solitary Fibrous Tumor, Pleural × Thoracic × 90 days × Clear all
NCT01064648 2026-05-29

Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma

National Cancer Institute (NCI)

Phase 1/2 Active not recruiting
117 enrolled 23 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT02399371 2026-05-08

Pembrolizumab in Treating Patients With Malignant Mesothelioma

University of Chicago

Phase 2 Completed
65 enrolled 12 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

Data powered by HemOnc (CC BY 4.0) Colophon âš¡